Matthew Lang
2019
In 2019, Matthew Lang earned a total compensation of $4.5M as General Counsel and Corporate Secretary at Myovant Sciences Ltd., a 146% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $232,000 |
|---|---|
| Option Awards | $3,560,864 |
| Salary | $430,000 |
| Stock Awards | $278,080 |
| Other | $2,054 |
| Total | $4,502,998 |
Lang received $3.6M in option awards, accounting for 79% of the total pay in 2019.
Lang also received $232K in non-equity incentive plan, $430K in salary, $278.1K in stock awards and $2.1K in other compensation.
Rankings
In 2019, Matthew Lang's compensation ranked 2,545th out of 13,971 executives tracked by ExecPay. In other words, Lang earned more than 81.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,545 out of 13,971 | 82nd |
Division Manufacturing | 915 out of 5,701 | 84th |
Major group Chemicals And Allied Products | 297 out of 2,200 | 87th |
Industry group Drugs | 239 out of 1,886 | 87th |
Industry Pharmaceutical Preparations | 175 out of 1,398 | 88th |
Source: SEC filing on July 24, 2020.
Lang's colleagues
We found two more compensation records of executives who worked with Matthew Lang at Myovant Sciences Ltd. in 2019.